MDGL实时信号 | 通过Getagraph.com最大化利润

购买 707 min ago

@ $230.59

发出时间: 4 May 2024 @ 03:13

回报率: -0.33%

上一信号: May 3 - 21:30

上一信号: 出售

回报率: 3.24 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):

Stats
今日成交量	433 785
平均成交量	612 738
市值	4.83B
EPS	$-5.68 ( 2024-02-29 )
下一个收益日期	( $-6.06 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.50
ATR14	$12.98 (5.67%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Taub Rebecca	Buy	2 676	Common Stock
2024-04-08	Taub Rebecca	Sell	224	Common Stock
2024-04-08	Taub Rebecca	Sell	945	Common Stock
2024-04-08	Taub Rebecca	Sell	300	Common Stock
2024-04-08	Taub Rebecca	Sell	600	Common Stock

INSIDER POWER
-31.13
Last 100 transactions
Buy: 220 053 \| Sell: 418 887

音量相关性

長: -0.74 (moderate negative)

短: 0.11 (neutral)

Signal:(48) Neutral

Madrigal Pharmaceuticals 相关性

10 最正相关
GOSS	0.82

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Madrigal Pharmaceuticals 相关性 - 货币/商品

0.04
( neutral )

-0.61
( weak negative )

-0.15
( neutral )

0.13
( neutral )

0.26
( neutral )

0.83
( strong )

Madrigal Pharmaceuticals 财务报表

Annual	2023
营收:	$0
毛利润:	$-527 000 (0.00 %)
EPS:	$-19.99

FY	2023
营收:	$0
毛利润:	$-527 000 (0.00 %)
EPS:	$-19.99

FY	2022
营收:	$0
毛利润:	$-467 000 (0.00 %)
EPS:	$-17.47

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-14.63

Financial Reports:

No articles found.

Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

实时更新： Madrigal Pharmaceuticals [MDGL]

Upcoming Earnings Alert